Tristan Lim Selected Research

Tec protein-tyrosine kinase

10/2023

Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tristan Lim Research Topics

Disease

1	Neoplasms (Cancer) 12/2023
1	Neutropenia 12/2023
1	Anemia 12/2023
1	Thrombocytopenia (Thrombopenia) 12/2023
1	Breast Neoplasms (Breast Cancer) 12/2023
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2023
1	Leukemia 10/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2023
1	Chronic Disease (Chronic Diseases) 01/2021
1	Vascular Remodeling 02/2018
1	Congenital Diaphragmatic Hernias 02/2018

Drug/Important Bio-Agent (IBA)

1	Proteasome InhibitorsIBA 10/2023
1	Tec protein-tyrosine kinaseIBA 10/2023
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	TRPC6 Cation ChannelIBA 02/2018
1	nitrofenIBA 02/2018

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2023 - 10/2023
1	Drug Tapering 12/2023
1	Adjuvant Chemotherapy 12/2023
1	Therapeutics 10/2023
1	Immunomodulation 01/2021